NM_000770.3:c.482-166A>G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000770.3(CYP2C8):c.482-166A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.378 in 152,074 control chromosomes in the GnomAD database, including 11,253 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as association (no stars).
Frequency
 Genomes: 𝑓 0.38   (  11253   hom.,  cov: 33) 
Consequence
 CYP2C8
NM_000770.3 intron
NM_000770.3 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -2.17  
Publications
6 publications found 
Genes affected
 CYP2C8  (HGNC:2622):  (cytochrome P450 family 2 subfamily C member 8) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize many xenobiotics, including the anticonvulsive drug mephenytoin, benzo(a)pyrene, 7-ethyoxycoumarin, and the anti-cancer drug taxol. This gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. Several transcript variants encoding a few different isoforms have been found for this gene. [provided by RefSeq, Nov 2010] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87). 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.47  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| CYP2C8 | NM_000770.3 | c.482-166A>G | intron_variant | Intron 3 of 8 | ENST00000371270.6 | NP_000761.3 | ||
| CYP2C8 | NM_001198853.1 | c.272-166A>G | intron_variant | Intron 3 of 8 | NP_001185782.1 | |||
| CYP2C8 | NM_001198855.1 | c.272-166A>G | intron_variant | Intron 4 of 9 | NP_001185784.1 | |||
| CYP2C8 | NM_001198854.1 | c.176-166A>G | intron_variant | Intron 2 of 7 | NP_001185783.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.378  AC: 57425AN: 151956Hom.:  11237  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
57425
AN: 
151956
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.378  AC: 57476AN: 152074Hom.:  11253  Cov.: 33 AF XY:  0.378  AC XY: 28104AN XY: 74374 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
57476
AN: 
152074
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
28104
AN XY: 
74374
show subpopulations 
African (AFR) 
 AF: 
AC: 
19741
AN: 
41468
American (AMR) 
 AF: 
AC: 
4902
AN: 
15280
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1438
AN: 
3468
East Asian (EAS) 
 AF: 
AC: 
2042
AN: 
5178
South Asian (SAS) 
 AF: 
AC: 
1928
AN: 
4822
European-Finnish (FIN) 
 AF: 
AC: 
3356
AN: 
10562
Middle Eastern (MID) 
 AF: 
AC: 
150
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
22668
AN: 
67980
Other (OTH) 
 AF: 
AC: 
880
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.501 
Heterozygous variant carriers
 0 
 1798 
 3596 
 5395 
 7193 
 8991 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 562 
 1124 
 1686 
 2248 
 2810 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1390
AN: 
3474
ClinVar
Significance: association 
Submissions summary: Other:1 
Revision: no assertion criteria provided
LINK: link 
Submissions by phenotype
Pulmonary disease, chronic obstructive, susceptibility to    Other:1 
Jul 05, 2022
HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas
Significance:association
Review Status:no assertion criteria provided
Collection Method:research
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.